11/13/2024
8:10 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
4:10 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:30 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:30 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/16/2024
8:01 AM | Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/16/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
11:15 PM | Tonix Pharmaceuticals (Filer)
| Form EFFECT | |
09/27/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:09 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
09/23/2024
6:08 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
4:03 PM | Tonix Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/19/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
6:23 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
4:00 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
09/10/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
4:17 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
08/30/2024
4:08 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
6:02 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
5:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:18 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/15/2024
5:03 AM | Tonix Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/12/2024
7:18 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:22 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:08 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:17 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/25/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
4:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
07/16/2024
8:12 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:48 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:33 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/08/2024
4:01 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/08/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
5:45 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
06/28/2024
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:09 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
3:52 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
3:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
06/13/2024
4:24 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/10/2024
7:53 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
10:21 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
4:10 PM | Taylor Carolyn E. (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Tonix Pharmaceuticals (Issuer)
Treco James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
7:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:56 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form ARS | |
04/15/2024
3:38 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
04/05/2024
3:47 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
03/29/2024
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
03/29/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:03 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
8:23 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
8:48 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:01 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4/A | |
03/06/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:05 PM | SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:06 PM | MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:07 PM | SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:08 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
7:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
6:00 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:31 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
3:53 PM | Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SC 13G | |
01/08/2024
4:07 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
3:33 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
01/02/2024
3:15 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
12/26/2023
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
12/21/2023
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
This company will win the AI race (Ad) Rome wasn’t built in a day…
But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence.
And without it, the entire AI industry would collapse.  You must read this new presentation from Porter Stansberry. |
12/21/2023
4:15 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
12/21/2023
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
9:31 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
6:00 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
4:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
6:10 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
